PATENT CLAIM ANALYSIS

Application Number: 16003967
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["435", "188000"]

Abstract:
The present disclosure relates to Cas9 nuclease variants and methods of producing and using such variants.

Claim (Index 113):
The genome editing system of  claim 108 , comprising a ribonucleoprotein (RNP) complex comprising the polypeptide and the guide nucleic acid.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 94.0
- Lexical Diversity: 1.13333
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15935334', '15208461', '15208228', '15060424', '15060448']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.592179870622195
- 35 USC 102 Novelty (BERT): 0.5303942979573463
- Combined Prediction Score: 0.5860013133557102
- Mean Citation Score: 328.594668
- Max Citation Score: 338.41968
- Similarity Product: 204.0957659180832

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test